Brokerages Set Church & Dwight Co., Inc. (NYSE:CHD) Target Price at $109.56

Shares of Church & Dwight Co., Inc. (NYSE:CHD) have been assigned a consensus rating of “Hold” from the eighteen research firms that are covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and eight have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $109.56.

A number of brokerages have commented on CHD. Piper Sandler started coverage on shares of Church & Dwight in a report on Tuesday, September 24th. They issued an “overweight” rating and a $120.00 target price for the company. Barclays reduced their price objective on shares of Church & Dwight from $86.00 to $85.00 and set an “underweight” rating for the company in a research note on Tuesday, November 5th. Wells Fargo & Company raised their target price on shares of Church & Dwight from $113.00 to $115.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. JPMorgan Chase & Co. upped their price target on Church & Dwight from $98.00 to $99.00 and gave the stock an “underweight” rating in a research report on Monday, November 4th. Finally, Morgan Stanley cut Church & Dwight from an “overweight” rating to an “equal weight” rating and set a $110.00 price objective for the company. in a research report on Monday, September 9th.

Insider Buying and Selling

In other news, CEO Matthew Farrell sold 165,823 shares of the stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $103.03, for a total transaction of $17,084,743.69. Following the sale, the chief executive officer now directly owns 112,719 shares of the company’s stock, valued at $11,613,438.57. This represents a 59.53 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Michael Read purchased 1,100 shares of the business’s stock in a transaction that occurred on Monday, December 16th. The stock was acquired at an average price of $106.82 per share, with a total value of $117,502.00. Following the purchase, the executive vice president now owns 2,505 shares in the company, valued at $267,584.10. This represents a 78.29 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have sold a total of 593,035 shares of company stock valued at $62,282,808 over the last ninety days. Company insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Church & Dwight

Hedge funds have recently bought and sold shares of the business. Capital Performance Advisors LLP acquired a new stake in Church & Dwight in the 3rd quarter valued at $27,000. Ashton Thomas Securities LLC acquired a new stake in shares of Church & Dwight in the third quarter valued at about $28,000. Versant Capital Management Inc increased its stake in shares of Church & Dwight by 224.4% during the fourth quarter. Versant Capital Management Inc now owns 266 shares of the company’s stock worth $28,000 after purchasing an additional 184 shares in the last quarter. Rothschild Investment LLC acquired a new position in shares of Church & Dwight during the 2nd quarter worth about $31,000. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in Church & Dwight in the 2nd quarter valued at about $33,000. Hedge funds and other institutional investors own 86.60% of the company’s stock.

Church & Dwight Stock Up 0.8 %

Shares of NYSE CHD opened at $104.64 on Wednesday. Church & Dwight has a 52-week low of $93.32 and a 52-week high of $113.50. The firm has a market capitalization of $25.64 billion, a price-to-earnings ratio of 46.92, a PEG ratio of 3.86 and a beta of 0.58. The stock has a 50 day moving average price of $106.72 and a 200 day moving average price of $104.20. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.09 and a current ratio of 1.62.

Church & Dwight (NYSE:CHD) last issued its quarterly earnings data on Friday, November 1st. The company reported $0.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.68 by $0.11. The company had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.50 billion. Church & Dwight had a net margin of 9.08% and a return on equity of 19.90%. Church & Dwight’s revenue was up 3.8% compared to the same quarter last year. During the same period last year, the company posted $0.74 earnings per share. Sell-side analysts expect that Church & Dwight will post 3.45 earnings per share for the current year.

Church & Dwight Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, December 2nd. Stockholders of record on Friday, November 15th were paid a $0.2838 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.14 dividend on an annualized basis and a dividend yield of 1.08%. Church & Dwight’s payout ratio is 50.67%.

Church & Dwight Company Profile

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.